Evolus to Participate in November Investor Conferences
01 Novembre 2023 - 1:45PM
Business Wire
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a
focus on building an aesthetic portfolio of consumer brands, today
announced that members of its management team will present at the
following investment conferences in November.
Event:
Stifel 2023 Healthcare Conference
Date:
Wednesday, November 15, 2023
Time:
11:30 AM ET
Event:
6th Annual Evercore ISI HealthCONx
Conference
Date:
Tuesday, November 28, 2023
Time:
9:35 AM ET
Audio webcasts of these events will be available on the investor
relations section of Evolus’ website at www.evolus.com. Replays of
the webcasts will be available for 90 days after the date of each
presentation.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving
the aesthetic neurotoxin market for the next generation of beauty
consumers through its unique, customer-centric business model and
innovative digital platform. Our mission is to become a global,
multi-product aesthetics company based on our flagship product,
Jeuveau® (prabotulinumtoxinA-xvfs), globally licensed under the
brand name Nuceiva®. The product is manufactured in a
state-of-the-art facility using Hi-Pure™ technology. Evolus is
expanding its product portfolio having entered into a definitive
agreement to be the exclusive U.S. distributor of Evolysse™, a line
of five unique dermal fillers currently in late-stage development.
Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram
or Facebook.
Jeuveau® and Nuceiva® are registered trademarks of Evolus, Inc.
Evolysse™ is a trademark of Evolus, Inc. Hi-Pure™ is a trademark of
Daewoong Pharmaceutical Co, Ltd.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231031666324/en/
Investor Contacts: Ned Mitchell
Arbor Advisory Group Email: ir@evolus.com
Media Contact: Email:
media@evolus.com
Evolus (NASDAQ:EOLS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Evolus (NASDAQ:EOLS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024